Results 191 to 200 of about 11,782,455 (235)
ABSTRACT Aims Adults with obesity are at increased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related fibrosis, but the diagnostic performance of non‐invasive tests (NITs) in this population remains uncertain. This meta‐analysis evaluated NITs for detecting significant (≥F2) and advanced (≥F3) fibrosis in adults with ...
Patricia M. Ortega +5 more
wiley +1 more source
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most prevalent chronic liver condition and is linked to unhealthy lifestyle patterns. Dietary modification remains the cornerstone of management. Among available nutritional strategies, ketogenic diets (KDs) have gained increasing attention.
Patrizia Palumbo +4 more
wiley +1 more source
Liver organoids: modelling complexity in homeostasis and disease
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley +1 more source
IL‐1β upregulates the protein level of WTAP, which promotes the m6A modification of ACSL4 mRNA in an IGF2BP2‐dependent manner, thereby enhancing its stability. The increased ACSL4 drives lipid peroxidation, leading to lysosomal membrane permeabilization (LMP) and impaired mitophagy, which collectively accelerate intervertebral disc degeneration (IVDD).
Shu Jia +8 more
wiley +1 more source
[Non-alcoholic steatohepatitis].
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Metformin in Non-Alcoholic Steatohepatitis
Lancet, The, 2001There is no established treatment for steatohepatitis in patients who are not alcoholics. This disease is a potentially progressive liver disease associated with hepatic insulin resistance. Only a weight-reducing diet in overweight patients has proved effective.
Giulio Marchesini +2 more
exaly +3 more sources
Medicina Clínica (English Edition), 2022
Non-alcoholic steatohepatitis belongs to the spectrum of metabolic-associated fatty liver diseases characterized by steatosis linked to obesity, diabetes, metabolic syndrome, dyslipidemia and immune-mediated disorders. The main features of MAFLD include high prevalence, heterogeneity, complexity and dynamic disease.
openaire +4 more sources
Non-alcoholic steatohepatitis belongs to the spectrum of metabolic-associated fatty liver diseases characterized by steatosis linked to obesity, diabetes, metabolic syndrome, dyslipidemia and immune-mediated disorders. The main features of MAFLD include high prevalence, heterogeneity, complexity and dynamic disease.
openaire +4 more sources
Diagnostic Histopathology, 2023
Steatohepatitis is a common non-infectious inflammatory disease of the liver, ranking 3rd or 4th in the structure of chronic progressive lesions of the organ. The prevalence of non-alcoholic forms of the disease in the population reaches 11–25 %. In obese patients, the pathology occurs 7 times more often than in those with normal weight.
Seung Hyun Lee, Tu Vinh Luong
openaire +2 more sources
Steatohepatitis is a common non-infectious inflammatory disease of the liver, ranking 3rd or 4th in the structure of chronic progressive lesions of the organ. The prevalence of non-alcoholic forms of the disease in the population reaches 11–25 %. In obese patients, the pathology occurs 7 times more often than in those with normal weight.
Seung Hyun Lee, Tu Vinh Luong
openaire +2 more sources
Non-alcoholic steatohepatitis (NASH)
Current Treatment Options in Gastroenterology, 1999Non-alcoholic steatohepatitis (NASH) is an increasingly common cause of persistently abnormal liver tests. Establishing a diagnosis of NASH requires the secure exclusion of alcohol abuse and hepatitis C as an alternate cause of liver injury. The gold standard of diagnosis is liver biopsy.
, Sorrell, , Mukherjee
openaire +2 more sources
Mechanisms of non-alcoholic steatohepatitis
Alcohol, 2004In 1980, the term non-alcoholic steatohepatitis was coined to describe a new syndrome occurring in patients who usually were obese (often diabetic) females who had a liver biopsy picture consistent with alcoholic hepatitis, but who denied alcohol use. The causes of this syndrome were unknown, and there was no defined therapy.
Craig J, McClain +6 more
openaire +2 more sources

